Research field (3):
Medical biochemistry
, Bioorganic chemistry
, Environmental and pharmaceutical development resources
Research theme for competitive and other funds (9):
2022 - 2025 Exploration and evaluation of low molecular weight thrombolytic agents that induce endogenous uPA expression
2020 - 2021 秋田県内で分離した微生物由来の新規抗菌物質の開発
2014 - 2017 Analysis of molecular targets and development into drug discovery for cyclic peptides possessing thrombolysis-enhancing action
2012 - 2015 The availability of combination therapy using G2 checkpoint inhibitor against radiation-sensitive solid tumor
2011 - 2011 天然物由来の環状ペプチドを基盤とした新規血栓溶解剤の開発
2010 - 2011 Development of radiation-sensitizing anti-cancer agents using G2 checkpoint aberogator
2008 - 2010 Chemical biology aimed at the development of new thrombolytics
2008 - 2008 高効率に糸状菌から生産されるイソフラボンを美白成分とした化粧品の開発
2006 - 2008 Development of the cell transplantation therapy for the tooth regeneration using the committed progenitor cell of the tooth established from the tooth germ
Show all
Papers (31):
Yushi Nagaki, Satoru Motoyama, Tomokazu Yamaguchi, Midori Hoshizaki, Yusuke Sato, Teruki Sato, Yukio Koizumi, Akiyuki Wakita, Yuta Kawakita, Kazuhiro Imai, et al. m(6)A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis. GENES TO CELLS. 2020. 25. 8. 547-561
日本血栓止血学会
, JAPANESE SOCIETY FOR CHEMICAL BIOLOGY
, SOCIETY FOR ACTINOMYCETES JAPAN
, THE JAPANESE BIOCHEMICAL SOCIETY
, JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY